2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Completed 1, Not yet recruiting 1 |
Follow Endocarditis, Bacterial: new trials by email Literature Review of Endocarditis, Bacterial trials Research Report on Endocarditis, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dalbavancin Therapy for Infective Endocarditis Dalbavancin administration, Standard of Care (Investigator Choice) - Endocarditis Infective, Endocarditis, Bacterial | Phase 3 | Not yet recruiting | Stefan Hagel | 184 | 2026-12-01 | 2026-07-13 |
| Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis Bacteriophage - Endocarditis, Bacterial | Phase 3 | Recruiting | University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) | 30 | 2025-02-05 | 2026-03-19 |
| New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected System Timing of reimplantation - Endocarditis, Bacterial | Phase 3 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 176 | 2024-04-29 | 2026-10-01 |
| Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus daptomycin - Bacterial Endocarditis, Bacteremia | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2002-03-01 | 2017-02-13 |
Endocarditis (3) · Bacteremia (1) · Gram-Positive Bacterial Infections (1) · Staphylococcal Infections (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Cardiovascular Diseases (4) · Cardiovascular Infections (4) · Heart Diseases (4) · Infections (4) · Endocarditis (1) · Inflammation (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sepsis (1) · Systemic Inflammatory Response Syndrome (1)
Daptomycin (1) · Standard of Care (1)
Copenhagen University Hospital, Rigshospitalet (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Stefan Hagel (1) · University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) (1)
Denmark (1) · Germany (1) · Russia (1)
Henning Henning (1)